Body Fluid Biomarkers for Alzheimer’s Disease—An Up-To-Date Overview
Neurodegeneration is a highly complex process which is associated with a variety of molecular mechanisms related to ageing. Among neurodegenerative disorders, Alzheimer’s disease (AD) is the most common, affecting more than 45 million individuals. The underlying mechanisms involve amyloid plaques an...
Main Authors: | Adrian Florian Bălașa, Cristina Chircov, Alexandru Mihai Grumezescu |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-10-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/8/10/421 |
Similar Items
-
Potential therapeutic roles of retinoids for prevention of neuroinflammation and neurodegeneration in Alzheimer’s disease
by: Bhaskar C Das, et al.
Published: (2019-01-01) -
Alzheimer’s Disease Animal Models: Elucidation of Biomarkers and Therapeutic Approaches for Cognitive Impairment
by: Tsuyoshi Nakai, et al.
Published: (2021-05-01) -
Insulin Resistance at the Crossroad of Alzheimer Disease Pathology: A Review
by: Jorge Berlanga-Acosta, et al.
Published: (2020-11-01) -
The neuropathological diagnosis of Alzheimer’s disease
by: Michael A. DeTure, et al.
Published: (2019-08-01) -
Alzheimer’s disease: A Threat to mankind
by: Poorti Pandey, et al.
Published: (2011-12-01)